William Bellamy
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
- Hematology 16
- Multiple Myeloma Research and Treatments 10
- Acute Myeloid Leukemia Research 4
- Oncology 26
- Drug Transport and Resistance Mechanisms 13
- Vascular Tumors and Angiosarcomas 5
- Co-authors
- Thomas M. GroganY FrutigerL RichterGarth PowisSarah J. WelshMargaret M. BriehlWilliam S. DaltonAlan F. List
- Journals
- Blood (5 papers)Anti-Cancer Drugs (3 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)Infection and Immunity (2 papers)Current Opinion in Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
William Bellamy
53 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 113
- Hematology 740
- Oncology 969
- Cancer Research 377
- Molecular Biology 1.7k
- Genetics 240
Countries citing papers authored by William Bellamy
This map shows the geographic impact of William Bellamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Bellamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Bellamy more than expected).
Fields of papers citing papers by William Bellamy
This network shows the impact of papers produced by William Bellamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Bellamy. The network helps show where William Bellamy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside William Bellamy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 14 | |
| 2 | 2018 | 3 | |
| 3 | 2012 | 18 | |
| 4 | 2012 | 82 | |
| 5 | 2007 | 20 | |
| 6 | 2005 | 38 | |
| 7 | 2004 | 51 | |
| 8 | 2002 | 9 | |
| 9 | 2001 | 89 | |
| 10 | 2001 | 277 | |
| 11 | 2000 | 163 | |
| 12 | 1996 | 16 | |
| 13 | 1996 | 249 | |
| 14 | 1996 | 9 | |
| 15 | 1994 | 51 | |
| 16 | 1992 | 70 | |
| 17 | 1990 | 46 | |
| 18 | 1990 | 0 | |
| 19 | 1989 | 29 | |
| 20 | Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration. | 1988 | 25 |
About William Bellamy
William Bellamy is a scholar working on Hematology, Oncology, Molecular Medicine, Endocrinology and Genetics, having authored 54 papers that have together received 2.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (13 papers), Multiple Myeloma Research and Treatments (10 papers), Cancer therapeutics and mechanisms (8 papers), Angiogenesis and VEGF in Cancer (8 papers), Vascular Tumors and Angiosarcomas (5 papers), Orthopedic Infections and Treatments (4 papers), Acute Myeloid Leukemia Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (740 citations), Oncology (969 citations), Cancer Research (377 citations), Molecular Biology (1.7k citations) and Genetics (240 citations). William Bellamy has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Thomas M. Grogan, Y Frutiger, L Richter, Garth Powis, Sarah J. Welsh, Margaret M. Briehl, William S. Dalton, Alan F. List, Lynne Richter and William S. Dalton. Their work appears in journals such as Blood, Anti-Cancer Drugs, JAIDS Journal of Acquired Immune Deficiency Syndromes, Infection and Immunity and Current Opinion in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.